Absorption, Distribution, Metabolism and Excretion Pharmacogenomics of Drugs of Abuse
Authors:
- 18 February 2011
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 12 (2) , 215-233
Abstract
Pharmacologic and toxic effects of xenobiotics, such as drugs of abuse, depend on the genotype and phenotype of an individual, and conversely on the isoenzymes involved in their metabolism and transport. The current knowledge of such isoenzymes of frequently abused therapeutics such as opioids (oxycodone, hydrocodone, methadone, fentanyl, buprenorphine, tramadol, heroin, morphine and codeine), anesthetics (γ-hydroxybutyric acid, propofol, ketamine and phencyclidine) and cognitive enhancers (methylphenidate and modafinil), and some important plant-derived hallucinogens (lysergide, salvinorin A, psilocybin and psilocin), as well as of nicotine in humans are summarized in this article. The isoenzymes (e.g., cytochrome P450, glucuronyltransferases, esterases and reductases) involved in the metabolism of drugs and some pharmacokinetic data are discussed. The relevance of such data is discussed for predicting possible interactions with other xenobiotics, understanding pharmacokinetic behavior and pharmacogenomi...Keywords
This publication has 207 references indexed in Scilit:
- Nicotine AddictionNew England Journal of Medicine, 2010
- Opioid MetabolismMayo Clinic Proceedings, 2009
- Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogenEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Nicotine Chemistry, Metabolism, Kinetics and Biomarkers2009
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular BasisThe American Journal of Human Genetics, 2008
- Poll results: look who's dopingNature, 2008
- Enantiospecific gas chromatographic–mass spectrometric analysis of urinary methylphenidate: Implications for phenotypingJournal of Chromatography B, 2008
- Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoproteinEuropean Journal of Pharmacology, 2008
- Interaction between buprenorphine and atazanavir or atazanavir/ritonavirDrug and Alcohol Dependence, 2007
- Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and PharmacodynamicsClinical Pharmacology & Therapeutics, 2007